|
EDC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.911210E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.785400E-01 |
| Normal-vs-Stage2 |
3.444800E-01 |
| Normal-vs-Stage3 |
1.320790E-01 |
| Normal-vs-Stage4 |
1.770970E-01 |
| Stage1-vs-Stage2 |
6.269600E-01 |
| Stage1-vs-Stage3 |
3.809000E-01 |
| Stage1-vs-Stage4 |
4.783600E-01 |
| Stage2-vs-Stage3 |
9.735000E-01 |
| Stage2-vs-Stage4 |
9.510200E-01 |
| Stage3-vs-Stage4 |
9.660400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.389400E-01 |
| Normal-vs-AfricanAmerican |
1.712400E-01 |
| Normal-vs-Asian |
8.472400E-01 |
| Caucasian-vs-AfricanAmerican |
5.067900E-02 |
| Caucasian-vs-Asian |
4.969200E-01 |
| AfricanAmerican-vs-Asian |
2.037600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.194600E-01 |
| Normal-vs-Female |
1.932790E-01 |
| Male-vs-Female |
8.809000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.340600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.184000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.724400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.818610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.459400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.541600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.473600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.722800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.007000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.060400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.077920E-02 |
| Classical-VS-Follicular |
5.958200E-03 |
| Classical-VS-Other |
2.124200E-01 |
| Classical-VS-Normal |
9.394800E-01 |
| Tall-VS-Follicular |
7.750800E-01 |
| Tall-VS-Other |
9.520400E-01 |
| Tall-VS-Normal |
1.274010E-02 |
| Follicular-VS-Other |
9.394000E-01 |
| Follicular-VS-Normal |
2.440100E-02 |
| Other-VS-Normal |
1.730370E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.562400E-01 |
| Normal-vs-N1 |
5.529500E-02 |
| N0-vs-N1 |
3.349600E-01 |
|
|
